Cetera Advisors LLC Tandem Diabetes Care Inc Transaction History

Cetera Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$53.22 - $123.09 $137,626 - $318,310	-2,586 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$101.89 - $150.09 $263,487 - $388,132	2,586 New	2,586 $301,000
Q1 2021 May 17, 2021	SELL	$81.28 - $104.34 $493,044 - $632,926	-6,066 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$86.4 - $121.75 $113,443 - $159,857	1,313 Added 27.62%	6,066 $580,000
Q3 2020 Nov 13, 2020	SELL	$95.43 - $116.09 $222,542 - $270,721	-2,332 Reduced 32.91%	4,753 $539,000
Q2 2020 Aug 13, 2020	SELL	$60.05 - $98.92 $5,824 - $9,595	-97 Reduced 1.35%	7,085 $701,000
Q1 2020 May 08, 2020	BUY	$47.37 - $90.04 $2,321 - $4,411	49 Added 0.69%	7,182 $462,000
Q4 2019 Feb 10, 2020	SELL	$53.13 - $71.19 $139,731 - $187,229	-2,630 Reduced 26.94%	7,133 $425,000
Q3 2019 Nov 06, 2019	SELL	$57.11 - $73.3 $179,896 - $230,895	-3,150 Reduced 24.39%	9,763 $579,000
Q2 2019 Aug 12, 2019	BUY	$54.41 - $71.7 $289,189 - $381,085	5,315 Added 69.95%	12,913 $832,000
Q1 2019 May 06, 2019	BUY	$32.25 - $73.56 $245,035 - $558,908	7,598 New	7,598 $485,000

344

72.7M

3.12M

343K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.73B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisors LLC with notifications on news.